Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Fitzgerald

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Phase I trial of continuous infusion anti-mesothelin recombinant immunotoxin SS1PRobert J Kreitman, Raffit Hassan, David J Fitzgerald, et al.
Molecular and Cellular Biology|May 12, 2010
Pseudomonas exotoxin A-mediated apoptosis is Bak dependent and preceded by the degradation of Mcl-1Xing Du, Richard J Youle, David J FitzGerald, et al.
Nature Reviews. Cancer|June 24, 2006
Immunotoxin therapy of cancerIra Pastan, Raffit Hassan, David J Fitzgerald, et al.
International Journal of Medical Microbiology : IJMM|May 20, 2004
Recombinant immunotoxins for treating cancerDavid J FitzGerald, Robert Kreitman, Wyndham Wilson, et al.
Blood|March 1, 2014
Immunotoxins for leukemiaAlan S Wayne, David J Fitzgerald, Robert J Kreitman, et al.
Cancer Research|October 15, 2011
Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugatesDavid J FitzGerald, Alan S Wayne, Robert J Kreitman, et al.
Drug Discovery Today|February 13, 2002
Bacterial toxins as tools for mucosal vaccinationRandall J Mrsny, Ann L Daugherty, Marian L McKee, et al.
Journal of Biomedical Science|March 21, 2008
Mammalian cell expression of an active site mutant of Pseudomonas exotoxin disrupts LRP1 maturationDiana V Pastrana, Cheol H Yun, Marian L McKee, et al.
Biochimica Et Biophysica Acta|August 13, 2005
LRP 1 B functions as a receptor for Pseudomonas exotoxinDiana V Pastrana, Alison J Hanson, Jane Knisely, et al.
Journal of Drug Delivery Science and Technology|April 27, 2026
Targeted delivery of RNA using synthetic bacterial sporesFederico Machinandiarena, Domenico D'Atri, Lisa M Jenkins, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Phase I trial of continuous infusion anti-mesothelin recombinant immunotoxin SS1PRobert J Kreitman, Raffit Hassan, David J Fitzgerald, et al.
Molecular and Cellular Biology|May 12, 2010
Pseudomonas exotoxin A-mediated apoptosis is Bak dependent and preceded by the degradation of Mcl-1Xing Du, Richard J Youle, David J FitzGerald, et al.
Nature Reviews. Cancer|June 24, 2006
Immunotoxin therapy of cancerIra Pastan, Raffit Hassan, David J Fitzgerald, et al.
International Journal of Medical Microbiology : IJMM|May 20, 2004
Recombinant immunotoxins for treating cancerDavid J FitzGerald, Robert Kreitman, Wyndham Wilson, et al.
Blood|March 1, 2014
Immunotoxins for leukemiaAlan S Wayne, David J Fitzgerald, Robert J Kreitman, et al.
Cancer Research|October 15, 2011
Treatment of hematologic malignancies with immunotoxins and antibody-drug conjugatesDavid J FitzGerald, Alan S Wayne, Robert J Kreitman, et al.
Drug Discovery Today|February 13, 2002
Bacterial toxins as tools for mucosal vaccinationRandall J Mrsny, Ann L Daugherty, Marian L McKee, et al.
Journal of Biomedical Science|March 21, 2008
Mammalian cell expression of an active site mutant of Pseudomonas exotoxin disrupts LRP1 maturationDiana V Pastrana, Cheol H Yun, Marian L McKee, et al.
Biochimica Et Biophysica Acta|August 13, 2005
LRP 1 B functions as a receptor for Pseudomonas exotoxinDiana V Pastrana, Alison J Hanson, Jane Knisely, et al.
Journal of Drug Delivery Science and Technology|April 27, 2026
Targeted delivery of RNA using synthetic bacterial sporesFederico Machinandiarena, Domenico D'Atri, Lisa M Jenkins, et al.
Pageof 5